For growth of non-syngeneic tumors, and of human origin tumors in particular, one can also cross HuCXCR4KI mice with recombination activating genes (Rag1 or Rag2) knockout mice (both commercially available in the same C57Bl6 background) to eliminate adaptive anti-tumor immunity and allow tumor establishment. The gene discussed is RAG1; the disease is neoplasm.